The content is available as a PDF (1.3 MB).
. 2022 Jun 16;162(7):S-1250–S-1251. doi: 10.1016/S0016-5085(22)63686-2
Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
Markos Kalligeros
, Fadi Shehadeh
, Savan Kothadia
, Daniel Marino
, Evangelia Mylona
, Jack R Wands
, Eleftherios Mylonakis
Markos Kalligeros
Find articles by Markos Kalligeros
Fadi Shehadeh
Find articles by Fadi Shehadeh
Savan Kothadia
Find articles by Savan Kothadia
Daniel Marino
Find articles by Daniel Marino
Evangelia Mylona
Find articles by Evangelia Mylona
Jack R Wands
Find articles by Jack R Wands
Eleftherios Mylonakis
Find articles by Eleftherios Mylonakis
Issue date 2022 May.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9212428